Human Genome Epidemiology Literature Finder
Records 1 - 4 (of 4 Records) |
Query Trace: Pruritus and EGFR[original query] |
---|
Epidermal growth factor receptor (EGFR) pathway polymorphisms as predictive markers of cetuximab toxicity in locally advanced head and neck squamous cell carcinoma (HNSCC) in a Spanish population. Oral oncology 2016 Dec 63 38-43. Fernández-Mateos J, Seijas-Tamayo R, Mesía R, Taberna M, Pastor Borgoñón M, Pérez-Ruiz E, Adansa Klain J C, Vázquez Fernández S, Del Barco Morillo E, Lozano A, González Sarmiento R, Cruz-Hernández J J, |
The Efficacy and Toxicity of Gefitinib in Treating Non-small Cell Lung Cancer: A Meta-analysis of 19 Randomized Clinical Trials. Journal of Cancer 2018 5 9 (8): 1455-1465. Wo Hongmei, He Jing, Zhao Yang, Yu Hao, Chen Feng, Yi Hongga |
Phase I Trial of a Third Generation EGFR Mutant-Selective Inhibitor (D-0316) in Patients with Advanced Non-Small Cell Lung Cancer. The oncologist 2022 3 27 (3): 163-e213. Jian Hong, Wang Kai, Cheng Ying, Ding Lieming, Wang Yang, Shi Zhe, Zhang Ling, Wang Yaolin, Lu Sh |
QL1706 (anti-PD-1 IgG4/CTLA-4 antibody) plus chemotherapy with or without bevacizumab in advanced non-small cell lung cancer: a multi-cohort, phase II study. Signal transduction and targeted therapy 2024 1 9 (1): 23. Yan Huang, Yunpeng Yang, Yuanyuan Zhao, Hongyun Zhao, Ningning Zhou, Yaxiong Zhang, Likun Chen, Ting Zhou, Gang Chen, Ting Wu, Lu Lu, Shilin Xue, Xiaoyan Kang, Li Zhang, Wenfeng Fa |
- Page last reviewed:Feb 1, 2024
- Content source: